Clinically, high IFI16 expression levels in patients of ESCC tend to correlate with poorer outcomes in terms of disease-free survival, positioning IFI16 as a promising prognostic marker for ESCC. The gene discussed is IFI16; the disease is esophageal squamous cell carcinoma.